A novel development is reshaping the copyright landscape: the increasing availability of 4-AcO-copyright, often known as "synthetic shrooms." Different from traditionally cultivated psilocybin mushrooms, this molecule is manufactured in laboratories, circumventing the difficulties of agricultural production. This transition has led to a significant